Immunosuppressive and monoclonal antibody treatment for myasthenia gravis: A network meta-analysis.

CNS Neurosci Ther · 2019 · PMC6488910 · PMID 30809966

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may not be significantno p-value reported

Third, the efficacy of AZA, MMF, MTX, and BLM may not be significant for MG treatment.

also in 2,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.